JEFFS ROGER
- SEC CIK
- 0001231615
在各公司的最新職務
- LQDA Liquidia Corp執行長2026/7/14 申報
- AXSM Axsome Therapeutics, Inc.董事2026/6/11 申報
交易紀錄
所有把 JEFFS ROGER 列為申報人的 Form 4，包括與他人共同申報的。每一列是一份申報裡同一種交易的合計；預設只顯示公開市場買進（P）與賣出（S）。
| 公司 | 申報時間（美東） | 交易日 | 內部人 | 交易 | 股數 | 均價 | 金額 | 交易後持股 | 持股變化 | 申報 |
|---|---|---|---|---|---|---|---|---|---|---|
| LQDALiquidia Corp | 2026/7/1420:07 ET | 2026/7/13 | JEFFS ROGER執行長 | S賣出Common Stock | −3.52 萬 | $71.5108 | −$252.07 萬 | 113.04 萬 | −3.0% | SEC10b5-1 |
| AXSMAxsome Therapeutics, Inc. | 2026/6/11 | 2026/6/10–6/11 | JEFFS ROGER董事 | S賣出Common Stock | −572 | $247.65 | −$14.17 萬 | 5.84 萬 | −1.0% | SEC10b5-1 |
| LQDALiquidia Corp | 2026/5/28 | 2026/5/27 | JEFFS ROGER執行長 | S賣出Common Stock | −6,428 | $62.18 | −$39.97 萬 | 104.17 萬 | −0.6% | SEC10b5-1 |
| LQDALiquidia Corp | 2026/5/26 | 2026/5/21–5/26 | JEFFS ROGER執行長 | S賣出Common Stock | −7.5 萬 | $61.01 | −$457.58 萬 | 104.81 萬 | −6.7% | SEC10b5-1 |
| LQDALiquidia Corp | 2026/5/20 | 2026/5/18–5/20 | JEFFS ROGER執行長 | S賣出Common Stock | −7.5 萬 | $58.9067 | −$441.8 萬 | 112.31 萬 | −6.3% | SEC10b5-1 |
| LQDALiquidia Corp | 2026/5/15 | 2026/5/13–5/15 | JEFFS ROGER執行長 | S賣出Common Stock | −7.5 萬 | $57.3167 | −$429.88 萬 | 119.81 萬 | −5.9% | SEC10b5-1 |
| LQDALiquidia Corp | 2026/5/12 | 2026/5/8–5/12 | JEFFS ROGER執行長 | S賣出Common Stock | −7.5 萬 | $45.8933 | −$344.2 萬 | 127.31 萬 | −5.6% | SEC10b5-1 |
| LQDALiquidia Corp | 2026/5/7 | 2026/5/5–5/7 | JEFFS ROGER執行長 | S賣出Common Stock | −7.5 萬 | $40.99 | −$307.43 萬 | 134.81 萬 | −5.3% | SEC10b5-1 |
| LQDALiquidia Corp | 2026/4/21 | 2026/4/17 | JEFFS ROGER執行長 | S賣出Common Stock | −1.88 萬 | $40.60 | −$76.49 萬 | 142.31 萬 | −1.3% | SEC10b5-1 |
| LQDALiquidia Corp | 2026/4/16 | 2026/4/14–4/16 | JEFFS ROGER執行長 | S賣出Common Stock | −5.33 萬 | $40.2111 | −$214.33 萬 | 144.19 萬 | −3.6% | SEC10b5-1 |
| LQDALiquidia Corp | 2026/4/14 | 2026/4/13 | JEFFS ROGER執行長 | S賣出Common Stock | −3.27 萬 | $38.37 | −$125.64 萬 | 113.76 萬 | −2.8% | SEC10b5-1 |
| LQDALiquidia Corp | 2026/4/14 | 2026/4/10 | JEFFS ROGER執行長 | S賣出Common Stock | −2.14 萬 | $40.12 | −$85.99 萬 | 149.52 萬 | −1.4% | SEC10b5-1 |
| LQDALiquidia Corp | 2026/4/13 | 2026/4/9 | JEFFS ROGER執行長 | S賣出Common Stock | −2.5 萬 | $40.12 | −$100.3 萬 | 151.67 萬 | −1.6% | SEC10b5-1 |
| LQDALiquidia Corp | 2026/1/13 | 2026/1/12 | JEFFS ROGER執行長 | S賣出Common Stock | −6.66 萬 | $37.43 | −$249.32 萬 | 103.75 萬 | −6.0% | SEC10b5-1 |
| LQDALiquidia Corp | 2025/10/15 | 2025/10/13 | JEFFS ROGER執行長 | S賣出Common Stock | −2.03 萬 | $23.41 | −$47.43 萬 | 103.3 萬 | −1.9% | SEC10b5-1 |
| AXSMAxsome Therapeutics, Inc. | 2025/9/2 | 2025/9/2 | JEFFS ROGER董事 | S賣出Common Stock | −1.35 萬 | $123.68 | −$166.52 萬 | 5.75 萬 | −19.0% | SEC10b5-1 |
| AXSMAxsome Therapeutics, Inc. | 2025/8/29 | 2025/8/27–8/29 | JEFFS ROGER董事 | S賣出Common Stock | −6 萬 | $121.7233 | −$730.34 萬 | 7.1 萬 | −45.8% | SEC10b5-1 |
| AXSMAxsome Therapeutics, Inc. | 2025/8/26 | 2025/8/22–8/26 | JEFFS ROGER董事 | S賣出Common Stock | −3.67 萬 | $120.0527 | −$440.52 萬 | 13.1 萬 | −21.9% | SEC10b5-1 |
| LQDALiquidia Corp | 2025/7/15 | 2025/7/14 | JEFFS ROGER執行長 | S賣出Common Stock | −2.03 萬 | $14.28 | −$28.92 萬 | 103.86 萬 | −1.9% | SEC10b5-1 |
| LQDALiquidia Corp | 2025/7/15 | 2025/7/14 | JEFFS ROGER執行長 | S賣出Common Stock | −2.03 萬 | $14.28 | −$28.92 萬 | 103.86 萬 | −1.9% | SEC10b5-1 |
| LQDALiquidia Corp | 2025/6/5 | 2025/6/4 | JEFFS ROGER執行長 | S賣出Common Stock | −3.06 萬 | $16.97 | −$51.95 萬 | 104.5 萬 | −2.8% | SEC10b5-1 |
| LQDALiquidia Corp | 2025/4/16 | 2025/4/14 | JEFFS ROGER執行長 | S賣出Common Stock | −1.41 萬 | $13.57 | −$19.17 萬 | 100.64 萬 | −1.4% | SEC10b5-1 |
| LQDALiquidia Corp | 2025/1/14 | 2025/1/14 | JEFFS ROGER執行長 | S賣出Common Stock | −2.23 萬 | $11.78 | −$26.32 萬 | 101.92 萬 | −2.1% | SEC10b5-1 |
| LQDALiquidia Corp | 2024/10/15 | 2024/10/14 | JEFFS ROGER執行長 | S賣出Common Stock | −8,053 | $11.11 | −$8.95 萬 | 81.22 萬 | −1.0% | SEC10b5-1 |
| LQDALiquidia Corp | 2024/7/15 | 2024/7/12 | JEFFS ROGER執行長 | S賣出Common Stock | −8,053 | $12.53 | −$10.09 萬 | 81.89 萬 | −1.0% | SEC10b5-1 |
| LQDALiquidia Corp | 2024/4/16 | 2024/4/12 | JEFFS ROGER執行長 | S賣出Common Stock | −8,360 | $14.58 | −$12.19 萬 | 82.7 萬 | −1.0% | SEC10b5-1 |
| LQDALiquidia Corp | 2024/3/19 | 2024/3/18 | JEFFS ROGER執行長 | S賣出Common Stock | −2.86 萬 | $15.82 | −$45.22 萬 | 83.53 萬 | −3.3% | SEC10b5-1 |
| AXSMAxsome Therapeutics, Inc. | 2024/3/15 | 2024/3/14–3/15 | JEFFS ROGER董事 | S賣出Common Stock | −3.23 萬 | $69.8387 | −$225.74 萬 | 12.08 萬 | −21.1% | SEC10b5-1 |
| LQDALiquidia Corp | 2023/12/18 | 2023/12/14 | JEFFS ROGER執行長 | P買進Common Stock | +13.97 萬 | $7.16 | +$100 萬 | 64.08 萬 | +27.9% | SEC |
| LQDALiquidia Corp | 2022/9/7 | 2022/9/6 | JEFFS ROGER執行長 | P買進Common Stock | +4.38 萬 | $5.57 | +$24.41 萬 | 15.98 萬 | +37.8% | SEC |
| LQDALiquidia Corp | 2022/5/25 | 2022/5/24 | JEFFS ROGER執行長 | P買進Common Stock | +2.8 萬 | $3.53 | +$9.88 萬 | 4.66 萬 | +150.6% | SEC |
| AXSMAxsome Therapeutics, Inc. | 2021/11/23 | 2021/11/19 | JEFFS ROGER董事 | P買進Common Stock | +3,950 | $37.30 | +$14.73 萬 | 12.08 萬 | +3.4% | SEC |